These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1283117)

  • 41. Finasteride for benign prostatic hypertrophy.
    Med Lett Drugs Ther; 1992 Sep; 34(878):83-4. PubMed ID: 1380630
    [No Abstract]   [Full Text] [Related]  

  • 42. Laboratory monitoring of androgenic activity in benign prostate hypertrophy treated with a 5 alpha-reductase inhibitor.
    Matzkin H; Chayen R; Goldfarb H; Gilad S; Braf Z
    Clin Chem; 1992 Jul; 38(7):1304-6. PubMed ID: 1377994
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism.
    Beshyah SA; Thomas E; Kyd P; Sharp P; Fairney A; Johnston DG
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):383-91. PubMed ID: 8187303
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia.
    Roehrborn CG; Boyle P; Nickel JC; Hoefner K; Andriole G;
    Urology; 2002 Sep; 60(3):434-41. PubMed ID: 12350480
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New options for patients with benign prostatic hyperplasia.
    Ellenberger B
    CMAJ; 1993 Feb; 148(4):543-7. PubMed ID: 7679313
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS).
    Nickel JC; Gilling P; Tammela TL; Morrill B; Wilson TH; Rittmaster RS
    BJU Int; 2011 Aug; 108(3):388-94. PubMed ID: 21631695
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A population-based nested case-control study: the use of 5-alpha-reductase inhibitors and the increased risk of osteoporosis diagnosis in patients with benign prostate hyperplasia.
    Lin WL; Hsieh YW; Lin CL; Sung FC; Wu CH; Kao CH
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):503-8. PubMed ID: 25158777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity.
    Imperato-McGinley J; Gautier T; Cai LQ; Yee B; Epstein J; Pochi P
    J Clin Endocrinol Metab; 1993 Feb; 76(2):524-8. PubMed ID: 8381804
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of finasteride (Proscar), a 5 alpha reductase inhibitor, and various commercial plant extracts in in vitro and in vivo 5 alpha reductase inhibition.
    Rhodes L; Primka RL; Berman C; Vergult G; Gabriel M; Pierre-Malice M; Gibelin B
    Prostate; 1993; 22(1):43-51. PubMed ID: 8381228
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Medical treatment of benign prostatic hyperplasia: 5 alpha-reductase inhibitors and alpha-adrenergic antagonists.
    Monda JM; Oesterling JE
    Mayo Clin Proc; 1993 Jul; 68(7):670-9. PubMed ID: 7688840
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of finasteride on serum testosterone and body mass index in men with benign prostatic hyperplasia.
    Roehrborn CG; Lee M; Meehan A; Waldstreicher J;
    Urology; 2003 Nov; 62(5):894-9. PubMed ID: 14624915
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of dutasteride on intraprostatic dihydrotestosterone concentrations in men with benign prostatic hyperplasia.
    Wurzel R; Ray P; Major-Walker K; Shannon J; Rittmaster R
    Prostate Cancer Prostatic Dis; 2007; 10(2):149-54. PubMed ID: 17189955
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dual control by androgens and peptide growth factors of prostatic growth in human benign prostatic hyperplasia.
    Serio M; Fiorelli G
    Mol Cell Endocrinol; 1991 Jun; 78(1-2):C77-81. PubMed ID: 1718792
    [No Abstract]   [Full Text] [Related]  

  • 54. Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia.
    Andriole G; Bruchovsky N; Chung LW; Matsumoto AM; Rittmaster R; Roehrborn C; Russell D; Tindall D
    J Urol; 2004 Oct; 172(4 Pt 1):1399-403. PubMed ID: 15371854
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy.
    Diamond T; Campbell J; Bryant C; Lynch W
    Cancer; 1998 Oct; 83(8):1561-6. PubMed ID: 9781950
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of long-term treatment with the dual 5 alpha-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasia.
    Debruyne F; Barkin J; van Erps P; Reis M; Tammela TL; Roehrborn C;
    Eur Urol; 2004 Oct; 46(4):488-94; discussion 495. PubMed ID: 15363566
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of long-term administration of finasteride (MK-906), an inhibitor of 5 alpha-reductase, in patients with benign prostatic hyperplasia.
    Yoshida O; Oishi K; Okada Y; Mizutani Y; Itokawa Y; Tomoyoshi T; Okada K; Komatz Y; Matsuda T; Takeuchi H
    Hinyokika Kiyo; 1996 Apr; 42(4):323-31. PubMed ID: 8693970
    [TBL] [Abstract][Full Text] [Related]  

  • 58. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1992 Sep; 268(11):1390. PubMed ID: 1380995
    [No Abstract]   [Full Text] [Related]  

  • 59. Changing attitudes in the treatment of benign prostatic hyperplasia: the role of 5 alpha-reductase inhibition. Proceedings of two symposia: Nice, France, November 11, 1989 and Amsterdam, The Netherlands, June 14, 1990.
    Eur Urol; 1991; 20 Suppl 1():1-86. PubMed ID: 1722153
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of finasteride on size of the prostate gland and semen quality in dogs with benign prostatic hypertrophy.
    Sirinarumitr K; Johnston SD; Kustritz MV; Johnston GR; Sarkar DK; Memon MA
    J Am Vet Med Assoc; 2001 Apr; 218(8):1275-80. PubMed ID: 11330612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.